SYNPO2 and prostate cancer: Inhibiting Synpo2-induced SF assembly also prevents Synpo2-enhanced prostate cancer cell migration in response to serum-stimulation [17], indicating a direct correlation between SF assembly and a Synpo2 pro-migratory phenotype.